Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
InSite to raise $22M to advance PhIII pipeline including combo product for lid margin disease
14 July 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
Not a subscriber?
Subscribe to Scrip
Request a FREE Trial
RELATED CONTENT
NEWS
Scrip News
Pfizer withdraws Macugen for DMO in Europe
Stockwatch: The perils of a successful biotech
Tesaro's $101 million series B to fund rolapitant PhIII and build oncology portfolio
End of an era in antibiotic blockbusters as FDA approves Levaquin generics
Other Informa News
The feeling’s mutual: Corin, Stryker end US Cormet distribution partnership
Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads